Evidence map›Paper›PMID 31703739›Full record

ArticleActa neuropathologica communications2019

In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy.

Maria Calvo-Rodriguez, Steven S Hou, Austin C Snyder, Simon Dujardin, Hamid Shirani, K Peter R Nilsson, Brian J Bacskai

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. BFACS applied bio materials · 2023
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Calvo-RodriguezAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114, 16th St, Charlestown, MA, 02129, USA.
Steven S HouAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114, 16th St, Charlestown, MA, 02129, USA.
Austin C SnyderAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114, 16th St, Charlestown, MA, 02129, USA.
Simon DujardinAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114, 16th St, Charlestown, MA, 02129, USA.
Hamid ShiraniDepartment of Physics, Chemistry and Biology, Linköping University, 581 83, Linköping, Sweden.
K Peter R NilssonDepartment of Physics, Chemistry and Biology, Linköping University, 581 83, Linköping, Sweden.
Brian J BacskaiAlzheimer Research Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114, 16th St, Charlestown, MA, 02129, USA. BBACSKAI@mgh.harvard.edu.

Funding

Atomic models of human tau filaments and development of tau ligandsU01NS110437 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI GHETTI, BERNARDINO FRANCESCO, JIANG, WEN · 2018 to 2022
$3.5M
Molecular pathways leading to neurodegeneration in vivoR01AG044263 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BACSKAI, BRIAN J · 2015 to 2019
$2.4M
Multiphoton microscopy for in vivo neural imagingR56AG060974 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BACSKAI, BRIAN J · 2019 to 2019
$598k
PREVENTIVE ONCOLOGY ACADEMIC AWARDK07CA000748 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ENSTROM, JAMES E · 1985 to 1985
–
Alzheimer's Association 2018-AARF-591935NIA NIH HHS R01 AG044263NIA NIH HHS R56 AG060974NIH HHS 1U01NS110437-01NIH HHS AG044263NIH HHS AG060974NINDS NIH HHS U01 NS110437
6 · The paper itself

Abstract

The detection of amyloid beta deposits and neurofibrillary tangles, both hallmarks of Alzheimer's disease (AD), is key to understanding the mechanisms underlying these pathologies. Luminescent conjugated oligothiophenes (LCOs) enable fluorescence imaging of these protein aggregates. Using LCOs and multiphoton microscopy, individual tangles and amyloid beta deposits were labeled in vivo and imaged longitudinally in a mouse model of tauopathy and cerebral amyloidosis, respectively. Importantly, LCO HS-84, whose emission falls in the green region of the spectrum, allowed for the first time longitudinal imaging of tangle dynamics following a single intravenous injection. In addition, LCO HS-169, whose emission falls in the red region of the spectrum, successfully labeled amyloid beta deposits, allowing multiplexing with other reporters whose emission falls in the green region of the spectrum. In conclusion, this method can provide a new approach for longitudinal in vivo imaging using multiphoton microscopy of AD pathologies as well as other neurodegenerative diseases associated with protein aggregation in mouse models.

Indexed as

Amyloid beta-PeptidesAnimalsBrainCerebral Amyloid AngiopathyDisease Models, AnimalFemaleLuminescent MeasurementsMaleMice, TransgenicMicroscopy, Fluorescence, MultiphotonNeurofibrillary TanglesProtein Aggregation, PathologicalTauopathiestau ProteinsAmyloid beta-Peptidestau ProteinsAlzheimer’s diseaseAmyloid beta plaquesCerebral amyloid angiopathyLuminescenceMultiphoton microscopyNeurofibrillary tanglesOligothiophenesTau

Identifiers

PMID31703739
PMCPMC6839235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.